Anfarm Hellas S.A. - Main Component
Active Substance | Strength | Form |
---|---|---|
Fluprednidene Acetate +Miconazole Nitrate | 0.1% + 2% (Tubx20g, x50g) | Cr.Ext.Us |
Imipenem + Cilastatin | (500+500)mg/Vial | Pd.Sol.Inf |
IsavuconazoleUnder Development | 200mg | Pd.C.So.In |
L-carnitine | 1g/10ml Vial | Oral.Sol |
Lacosamide | 10mg/ml | Sol.Inf |
Lacosamide | 10mg/ml | Oral Solution |
LetermovirUnder Development | 240&480mg/vial | C.So.In |
LetermovirUnder Development | 240&480mg/tab | F.C. tabs |
Levofloxacin | 5mg/ml (100ml Bottle) | Sol.Inf |
Linezolid | 2mg/ml (300ml Plastic Bag) | Sol.Inf |
Lisinopril | 20mg, 40mg | Tab |
Loratadine | 10mg | Tab |
Losartan Potassium | 100mg | F.C.Tab |
Meropenem | 500mg,1g,2g/Vial | Pd.I.S.Inf |
Moxifloxacin | 400mg/250ml (250ml Bottle) | Sol.Inf |
Nimodipine | 30mg | F.C.Tab |
Norfloxacin | 400mg | F.C.Tab |
Omeprazole | 40mg/Vial | Ps.Inj.Sol |
Omeprazole | 20mg, 40mg | GR.Cap |
Omeprazole | 40mg/Vial | Pd.Sol.Inf |
Active Substance | Strength | Form |
---|---|---|
Fluprednidene Acetate +Miconazole Nitrate | 0.1% + 2% (Tubx20g, x50g) | Cr.Ext.Us |
Imipenem + Cilastatin | (500+500)mg/Vial | Pd.Sol.Inf |
IsavuconazoleUnder Development | 200mg | Pd.C.So.In |
L-carnitine | 1g/10ml Vial | Oral.Sol |
Lacosamide | 10mg/ml | Sol.Inf |
Lacosamide | 10mg/ml | Oral Solution |
LetermovirUnder Development | 240&480mg/vial | C.So.In |
LetermovirUnder Development | 240&480mg/tab | F.C. tabs |
Levofloxacin | 5mg/ml (100ml Bottle) | Sol.Inf |
Linezolid | 2mg/ml (300ml Plastic Bag) | Sol.Inf |
Lisinopril | 20mg, 40mg | Tab |
Loratadine | 10mg | Tab |
Losartan Potassium | 100mg | F.C.Tab |
Meropenem | 500mg,1g,2g/Vial | Pd.I.S.Inf |
Moxifloxacin | 400mg/250ml (250ml Bottle) | Sol.Inf |
Nimodipine | 30mg | F.C.Tab |
Norfloxacin | 400mg | F.C.Tab |
Omeprazole | 40mg/Vial | Ps.Inj.Sol |
Omeprazole | 20mg, 40mg | GR.Cap |
Omeprazole | 40mg/Vial | Pd.Sol.Inf |
Active Substance | Strength | Form | Market Availability |
---|---|---|---|
Fluprednidene Acetate +Miconazole Nitrate | 0.1% + 2% (Tubx20g, x50g) | Cr.Ext.Us | Selected Markets |
Imipenem + Cilastatin | (500+500)mg/Vial | Pd.Sol.Inf | International |
IsavuconazoleUnder Development | 200mg | Pd.C.So.In | Q2 2024 |
L-carnitine | 1g/10ml Vial | Oral.Sol | International |
Lacosamide | 10mg/ml | Sol.Inf | International |
Lacosamide | 10mg/ml | Oral Solution | International |
LetermovirUnder Development | 240&480mg/vial | C.So.In | TBC |
LetermovirUnder Development | 240&480mg/tab | F.C. tabs | TBC |
Levofloxacin | 5mg/ml (100ml Bottle) | Sol.Inf | International |
Linezolid | 2mg/ml (300ml Plastic Bag) | Sol.Inf | International |
Lisinopril | 20mg, 40mg | Tab | Selected Markets |
Loratadine | 10mg | Tab | Selected Markets |
Losartan Potassium | 100mg | F.C.Tab | Selected Markets |
Meropenem | 500mg,1g,2g/Vial | Pd.I.S.Inf | International |
Moxifloxacin | 400mg/250ml (250ml Bottle) | Sol.Inf | International |
Nimodipine | 30mg | F.C.Tab | Selected Markets |
Norfloxacin | 400mg | F.C.Tab | Selected Markets |
Omeprazole | 40mg/Vial | Ps.Inj.Sol | International |
Omeprazole | 20mg, 40mg | GR.Cap | International |
Omeprazole | 40mg/Vial | Pd.Sol.Inf | International |